FOSTER CITY, CA / ACCESS Newswire / February 19, 2025 / MATRIXX Software, a global leader in billing and monetization solutions, today announced the launch of its groundbreaking product, MATRIXX ...
The pharmaceutical industry should cringe in horror at the U.S. Supreme Court's decision to hear a case which asks whether Matrixx (MTXX), the company that markets cold treatment Zicam, had a duty to ...
FOSTER CITY, CA / ACCESS Newswire / October 13, 2025 / MATRIXX Software, a global leader in monetization solutions, proudly celebrates the 25th anniversary of the 3GPP SA5 Charging Working Group, a ...
5G monetisation solution Matrixx Software renews its deal with Telstra to provide monetisation across the telco’s 4G and 5G networks. The renewed partnership comes in timely as Telstra is investing in ...
SARATOGA, Calif.--(BUSINESS WIRE)--MATRIXX Software (http://www.matrixx.com) today announced a $40 million Series C funding led by Sutter Hill Ventures. Stefan ...
SKILLMAN, N.J. — Matrixx Initiatives on Tuesday announced its second overture to ProPhase Labs with an increased acquisition offer of $1.60 per share. The revised offer represents a premium of 51.7% ...
SKILLMAN, N.J., Oct. 9, 2012 /PRNewswire/ -- Matrixx Initiatives, Inc., the maker of the Zicam® cold, sinus and allergy line of products, announced today that it has increased its offer to acquire all ...
Matrixx Initiatives claims the FDA's ban of Zicam cold remedy nasal swabs is political and the company is the victim -- not the 130 people who lost their sense of smell. Meanwhile, the SEC has joined ...
Breakthrough in processing technologies drastically reduces the cost of billing operations FOSTER CITY, CA / ACCESS Newswire / February 19, 2025 / MATRIXX Software, a global leader in billing and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results